Examkin

Soru

Zorluk: ZorEnd-of-Life and Palliative Care

A 78-year-old man with advanced idiopathic pulmonary fibrosis and cor pulmonale is enrolled in home hospice care. His functional status has declined rapidly over the past two weeks, and he is now entirely bedbound. He has an active do-not-resuscitate (DNR) and do-not-intubate (DNI) order in place. Over the last 24 hours, he has experienced progressively worsening shortness of breath. His respiratory rate is 28/min, and his oxygen saturation is 86% on 4 L/min via nasal cannula. He appears distressed, agitated, and is using accessory muscles of respiration. The hospice nurse arrives to evaluate the patient and optimize his symptom management.

Arrange the following interventions in the most appropriate stepwise sequence for escalating the management of this patient's terminal dyspnea, assuming each preceding step has been maximized but failed to provide adequate symptomatic relief.

  1. 1Maximize non-pharmacologic interventions, such as directing cool air to the face with a bedside fan and optimizing patient positioning.
  2. 2Administer low-dose immediate-release oral or sublingual opioids.
  3. 3Titrate the opioid dose and transition to a continuous parenteral opioid infusion.
  4. 4Add a scheduled or as-needed benzodiazepine to manage the severe anxiety component of his dyspnea.
  5. 5Institute palliative sedation with a continuous infusion of an agent such as midazolam or propofol.

Cevap

The correct stepwise escalation for terminal dyspnea management is: (1) Non-pharmacologic interventions, (2) Immediate-release oral/sublingual opioids, (3) Continuous parenteral opioid infusion, (4) Addition of an adjunctive benzodiazepine, and (5) Palliative sedation.
The management of terminal dyspnea follows a stepwise escalation based on symptom severity and response to treatment. Non-pharmacologic measures (e.g., cool air via a fan, elevating the head of the bed) are the safest initial step. Opioids are the gold standard first-line pharmacologic treatment for dyspnea, typically started as low-dose immediate-release formulations. If symptoms persist or the patient loses the ability to swallow, transitioning to a continuous parenteral opioid infusion is indicated. If dyspnea remains refractory and is accompanied by prominent anxiety or panic, adding an adjunctive benzodiazepine is appropriate. Finally, if the patient experiences intractable, refractory suffering despite maximized medical therapy, palliative sedation (intentional lowering of consciousness) is the universally accepted treatment of last resort.

Adım Adım Çözüm

1
Identify the primary clinical challenge and care context.
The patient is experiencing severe, escalating terminal dyspnea in a home hospice setting.
Recognizing the end-of-life context and DNR/DNI status dictates a purely symptom-directed, palliative approach rather than disease-modifying or invasive therapy.
2
Determine the safest initial non-pharmacologic approach.
Positioning and utilizing a bedside fan to direct cool air to the face.
These interventions carry zero risk, are immediately available, and effectively stimulate trigeminal afferents to reduce the central sensation of breathlessness.
3
Establish the first-line pharmacologic standard of care.
Initiation of low-dose immediate-release opioids.
Opioids are the most effective pharmacologic treatment for dyspnea, acting to decrease the central respiratory drive and alter the subjective perception of breathlessness.
4
Determine the escalation strategy if initial pharmacologic steps fail to provide relief.
Transition to continuous parenteral opioids, then add benzodiazepines, and finally consider palliative sedation as a last resort.
Continuous infusions provide steady-state relief. Benzodiazepines address the anxiety/panic cycle that exacerbates dyspnea. Palliative sedation is strictly reserved for when all other therapies fail to relieve unbearable suffering.

Anahtar Kavram

The stepwise management of refractory terminal dyspnea prioritizes non-pharmacologic measures, followed by opioids (the gold standard pharmacologic therapy), adjunctive anxiolytics for associated panic, and palliative sedation as a final resort.
Bu soruyu puanla

Konular

End-of-Life and Palliative Care

Bu konudan daha fazla soru